Lite Strategy, Inc. SEC filings LITS

Lite Strategy, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Oct 21, 2004. Its latest annual report, Form 10-K, was filed on Sep 28, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (unregistered share sale). The company's fiscal year ends on June 30.

Lite Strategy, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Jan 27, 2026 —
DEFA14A Additional proxy material Dec 30, 2025 —
DEF 14A Proxy statement Dec 30, 2025 Dec 30, 2025
DEFA14A Additional proxy material Dec 20, 2024 —
DEF 14A Proxy statement Dec 20, 2024 Dec 20, 2024
DEFA14A Additional proxy material Nov 8, 2023 —
DEF 14A Proxy statement Nov 8, 2023 Nov 8, 2023
DEFA14A Additional proxy material Nov 1, 2023 —
DEFA14A Additional proxy material Oct 18, 2023 —
DEFA14A Additional proxy material Oct 2, 2023 —
DEFA14A Additional proxy material Sep 28, 2023 —
DEFA14A Additional proxy material Sep 18, 2023 —
DEFA14A Additional proxy material Jun 1, 2023 —
DEFA14A Additional proxy material May 31, 2023 —
DEF 14A Proxy statement Oct 27, 2022 Dec 6, 2022
PRE 14A Preliminary proxy statement Oct 14, 2022 Dec 6, 2022
DEFA14A Additional proxy material Nov 23, 2021 —
DEFA14A Additional proxy material Oct 28, 2021 —
DEF 14A Proxy statement Oct 28, 2021 Dec 16, 2021
PRE 14A Preliminary proxy statement Oct 6, 2021 Dec 16, 2021
DEF 14A Proxy statement Oct 27, 2020 Dec 16, 2020
DEF 14A Proxy statement Oct 23, 2019 Dec 5, 2019
DEFA14A Additional proxy material Oct 11, 2018 —
DEF 14A Proxy statement Oct 11, 2018 Nov 29, 2018
PRE 14A Preliminary proxy statement Sep 14, 2018 Sep 14, 2018
DEFA14A Additional proxy material Oct 16, 2017 —
DEF 14A Proxy statement Oct 16, 2017 Nov 30, 2017
DEFA14A Additional proxy material Oct 17, 2016 —
DEF 14A Proxy statement Oct 17, 2016 Dec 1, 2016
DEFA14A Additional proxy material Oct 16, 2015 —
DEF 14A Proxy statement Oct 16, 2015 Dec 3, 2015
DEFA14A Additional proxy material Oct 17, 2014 —
DEF 14A Proxy statement Oct 17, 2014 Dec 3, 2014
PRE 14A Preliminary proxy statement Oct 1, 2014 Dec 3, 2014
DEFA14A Additional proxy material Oct 18, 2013 —
DEF 14A Proxy statement Oct 18, 2013 Dec 5, 2013
DEFA14A Additional proxy material Feb 13, 2013 —
DEF 14A Proxy statement Feb 13, 2013 Mar 26, 2013
PRE 14A Preliminary proxy statement Feb 1, 2013 Mar 26, 2013
DEF 14C Information statement Nov 28, 2012 Nov 28, 2012
PRE 14C Preliminary information statement Nov 9, 2012 Nov 9, 2012
DEF 14A Proxy statement Oct 28, 2011 Dec 1, 2011
DEF 14C Information statement Jul 5, 2011 Jul 5, 2011
PRE 14C Preliminary information statement Jun 3, 2011 Jun 3, 2011
DEF 14A Proxy statement Mar 15, 2011 Apr 13, 2011
DEFA14A Additional proxy material Mar 19, 2010 —
DEF 14A Proxy statement Feb 26, 2010 Mar 29, 2010
PRE 14A Preliminary proxy statement Feb 9, 2010 Mar 29, 2010
DEFA14A Additional proxy material Feb 9, 2010 —
DEF 14A Proxy statement Oct 22, 2009 Dec 8, 2009
DEF 14A Proxy statement Oct 24, 2008 Dec 9, 2008
DEF 14A Proxy statement Oct 25, 2007 Dec 19, 2007
DEFA14A Additional proxy material Nov 27, 2006 —
DEF 14A Proxy statement Oct 30, 2006 Dec 12, 2006
PRE 14A Preliminary proxy statement Oct 6, 2006 Dec 12, 2006
DEF 14A Proxy statement Oct 27, 2005 Nov 30, 2005
PRE 14A Preliminary proxy statement Oct 11, 2005 Nov 30, 2005
DEF 14A Proxy statement Oct 28, 2004 Dec 16, 2004

Showing 58 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Finance Services (SIC 6199)
Listed as
LITS (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1262104
Former names
MEI Pharma, Inc. (until Sep 10, 2025); MARSHALL EDWARDS INC (until Jun 6, 2012)

Other Finance Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.